Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplantation

M A Hardy1, E R Goodman

  • 1College of Physicians and Surgeons, Columbia University, New York, NY.

JAMA
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Parent-to-child organ transplants carry a high risk of acute rejection. Newer immunosuppressive drugs targeting T- and B-lymphocytes are being investigated to improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidneys at higher risk of discard: expanding the role of dual kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Microscopic intrarenal particles after pulsatile machine preservation do not adversely affect outcomes after renal transplantation.

Transplantation proceedings·2006
Same author

Validation of the scoring system for standardization of the pancreatic donor for islet isolation as used in a new islet isolation center.

Transplantation proceedings·2006
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Area of Science:

  • Transplantation immunology
  • Immunosuppressive therapy

Background:

  • Parent-to-child organ transplantation presents a significant risk of acute rejection.
  • Existing immunosuppressive strategies require optimization for this specific patient population.

Purpose of the Study:

  • To evaluate the efficacy of novel immunosuppressive agents in preventing acute rejection following parent-to-child transplantation.
  • To explore agents that modulate both T- and B-lymphocyte function.

Main Methods:

  • Review of current literature on immunosuppression in pediatric transplantation.
  • Analysis of clinical data on newer immunosuppressive agents targeting lymphocyte function.

Main Results:

  • Parent-to-child transplants show a higher incidence of acute rejection compared to other transplant types.

Related Experiment Videos

  • Emerging immunosuppressants inhibiting T- and B-cells demonstrate potential therapeutic benefits.

    • Conclusions:

    • Novel immunosuppressive agents offer a promising avenue for reducing acute rejection in parent-to-child transplants.
    • Targeting both T- and B-lymphocytes may enhance graft survival.